Home›Research›Compare›AOD-9604 vs IGF-2
Peptide ComparisonAOD-9604 vs IGF-2
Both are GH / IGF Axis peptides.
AOD-9604
Advanced Obesity Drug 9604
Half-life: 30–60 minutes
195 providers listed
IGF-2
Insulin-like Growth Factor 2
Half-life: ~10-20 minutes
No providers listed yet
IGF-2 carries stronger published evidence (Cohort study, 8 key studies) than AOD-9604 (Animal, 1); both are research compounds.
AOD-9604
Evidence
Half-life
30–60 minutes
IGF-2
Evidence
Half-life
~10-20 minutes
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | IGF-2 |
| Less frequent dosing (longer half-life) | AOD-9604 |
| Oral administration option | AOD-9604 |
| More provider options (195 vs 0) | AOD-9604 |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
AOD-9604
IGF-2
AOD-9604
IGF-2
An engineered insulin analog with dual insulin and IGF-1 receptor agonism and distinct signaling.
Paraneoplastic hypoglycemia as the initial presentation of a pancreatic neuroendocrine tumor.
Proteomics and ex vivo plaque culture identify the insulin-like growth factor axis as a potential regulator o…
The IGF signaling axis in thyroid cancer: biological complexity and therapeutic challenges.
+4 more
About AOD-9604
AOD-9604 stimulates lipolysis and inhibits lipogenesis through mechanisms believed to be independent of the insulin-like growth factor pathway. It appears to mimic the fat-metabolising action of growth hormone without triggering the proliferative effects associated with full GH or GH-releasing peptides. Oral bioavailability has been observed in some formulations, making it of interest for non-injectable protocols.
About IGF-2
Binds IGF-1R and insulin receptor variant A; promotes anabolic signaling in muscle and fat; activates PI3K/Akt/mTOR pathway; different receptor binding profile than IGF-1
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
AOD-9604
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
IGF-2
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
AOD-9604
IGF-2
Not enough vendor pricing yet.
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More GH / IGF Axis Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 20, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). AOD-9604 vs IGF-2 — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/aod-9604/igf-2